BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND WT1, WAGR, 7490, ENSG00000184937, WT33, GUD, WIT-2 AND Prognosis
31 results:

  • 1. Hypoplastic form of myelodysplastic neoplasm.
    Votavová H; Lenertová Z; Votava T; Beličková M
    Klin Onkol; 2023; 36(3):206-214. PubMed ID: 37353349
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A global study for acute myeloid leukemia with RARG rearrangement.
    Zhu HH; Qin YZ; Zhang ZL; Liu YJ; Wen LJ; You MJ; Zhang C; Such E; Luo H; Yuan HJ; Zhou HS; Liu HX; Xu R; Li J; Li JH; Hao JP; Jin J; Yu L; Zhang JY; Liu LP; Zhang LP; Huang RB; Shen SH; Gao SJ; Wang W; Yan XJ; Zhang XY; Du X; Chu XX; Yu YF; Wang Y; Mi YC; Lu Y; Cai Z; Su Z; Taussig DC; MacMahon S; Ball ED; Wang HY; Welch JS; Yin CC; Borthakur G; Sanz MA; Kantarjian HM; Huang JY; Hu J; Chen SN
    Blood Adv; 2023 Jul; 7(13):2972-2982. PubMed ID: 36799929
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical utility of genomic profiling of AML using paraffin-embedded bone marrow clots: HM-SCREEN-Japan 01.
    Hosono N; Chi S; Yamauchi T; Fukushima K; Shibayama H; Katagiri S; Gotoh A; Eguchi M; Morishita T; Ogasawara R; Kondo T; Yanada M; Yamamoto K; Kobayashi T; Kuroda J; Usuki K; Utsu Y; Yoshimitsu M; Ishitsuka K; Ono T; Takahashi N; Iyama S; Kojima K; Nakamura Y; Fukuhara S; Izutsu K; Abutani H; Yamauchi N; Yuda J; Minami Y;
    Cancer Sci; 2023 May; 114(5):2098-2108. PubMed ID: 36793248
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Small round cell sarcomas.
    Cidre-Aranaz F; Watson S; Amatruda JF; Nakamura T; Delattre O; de Alava E; Dirksen U; Grünewald TGP
    Nat Rev Dis Primers; 2022 Oct; 8(1):66. PubMed ID: 36202860
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. NUT carcinoma, an under-recognized malignancy: a clinicopathologic and molecular series of 6 cases showing a subset of patients with better prognosis and a rare ZNF532::NUTM1 fusion.
    Abreu RF; Oliveira TB; Hertzler H; Toledo RN; D'Almeida Costa F; Lopes Pinto CA; Nunes WA; Nascimento AF; French CA; Nascimento AG
    Hum Pathol; 2022 Aug; 126():87-99. PubMed ID: 35623465
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT.
    Kinoshita H; Cooke KR; Grant M; Stanojevic M; Cruz CR; Keller M; Fortiz MF; Hoq F; Lang H; Barrett AJ; Liang H; Tanna J; Zhang N; Shibli A; Datar A; Fulton K; Kukadiya D; Zhang A; Williams KM; Dave H; Dome JS; Jacobsohn D; Hanley PJ; Jones RJ; Bollard CM
    Blood Adv; 2022 Apr; 6(8):2520-2534. PubMed ID: 35244681
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prognostic significance of long non coding maternally expressed gene 3 in pediatric acute myeloid leukemia.
    Xue H; Gao H; Xia H; Li S; Li N; Duan Y; Ren Y; Zhang H; Liu J; Gao W
    Medicine (Baltimore); 2021 Sep; 100(35):e26959. PubMed ID: 34477125
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [CASC5 Gene Expression Changes Correlate with Targeted Mutations in Leukemia].
    Bogdanov KV; Merzlikina OV; Mirolyubova YV; Girshova LL; Lomaia EG; Zaritskey AY
    Mol Biol (Mosk); 2021; 55(1):139-151. PubMed ID: 33566033
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. TP-0903 is active in models of drug-resistant acute myeloid leukemia.
    Jeon JY; Buelow DR; Garrison DA; Niu M; Eisenmann ED; Huang KM; Zavorka Thomas ME; Weber RH; Whatcott CJ; Warner SL; Orwick SJ; Carmichael B; Stahl E; Brinton LT; Lapalombella R; Blachly JS; Hertlein E; Byrd JC; Bhatnagar B; Baker SD
    JCI Insight; 2020 Dec; 5(23):. PubMed ID: 33268594
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. bone marrow microenvironments that contribute to patient outcomes in newly diagnosed multiple myeloma: A cohort study of patients in the Total Therapy clinical trials.
    Danziger SA; McConnell M; Gockley J; Young MH; Rosenthal A; Schmitz F; Reiss DJ; Farmer P; Alapat DV; Singh A; Ashby C; Bauer M; Ren Y; Smith K; Couto SS; van Rhee F; Davies F; Zangari M; Petty N; Orlowski RZ; Dhodapkar MV; Copeland WB; Fox B; Hoering A; Fitch A; Newhall K; Barlogie B; Trotter MWB; Hershberg RM; Walker BA; Dervan AP; Ratushny AV; Morgan GJ
    PLoS Med; 2020 Nov; 17(11):e1003323. PubMed ID: 33147277
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data.
    Fernández-Navarro P; López-Nieva P; Piñeiro-Yañez E; Carreño-Tarragona G; Martinez-López J; Sánchez Pérez R; Aroca Á; Al-Shahrour F; Cobos-Fernández MÁ; Fernández-Piqueras J
    BMC Cancer; 2019 Oct; 19(1):1005. PubMed ID: 31655559
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. wt1 regulates cyclin A1 expression in K562 cells.
    Pandey S; Moazam M; Ghimirey N; Kuerbitz SJ; Fraizer GC
    Oncol Rep; 2019 Nov; 42(5):2016-2028. PubMed ID: 31436300
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. ssExpression level of GAS6-mRNA influences the prognosis of acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation.
    Yang X; Shi J; Zhang X; Zhang G; Zhang J; Yang S; Wang J; Ke X; Fu L
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 31028135
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Molecular Genetic Characterization of Acute Myeloid Leukemia With Trisomy 4 as the Sole Chromosome Abnormality.
    Torkildsen S; Gorunova L; Heim S; Tjønnfjord GE; Spetalen S; Risberg B; Tran HTT; Panagopoulos I
    Cancer Genomics Proteomics; 2019; 16(3):175-178. PubMed ID: 31018948
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Wilms Tumor 1 Expression at Diagnosis Correlates With Genetic Abnormalities and Polymorphism But Is Not Independently Prognostic in Acute Myelogenous Leukemia: A Hokkaido Leukemia Net Study.
    Hidaka D; Onozawa M; Hashiguchi J; Miyashita N; Kasahara K; Fujisawa S; Hayase E; Okada K; Shiratori S; Goto H; Sugita J; Nakagawa M; Hashimoto D; Kahata K; Endo T; Yamamoto S; Tsutsumi Y; Haseyama Y; Nagashima T; Mori A; Ota S; Sakai H; Ishihara T; Imai K; Miyagishima T; Kakinoki Y; Kurosawa M; Kobayashi H; Iwasaki H; Shimizu C; Kondo T; Teshima T
    Clin Lymphoma Myeloma Leuk; 2018 Nov; 18(11):e469-e479. PubMed ID: 30082223
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Late recurrence of pStage 1 low-grade serous ovarian tumor presenting as a symptomatic bone metastasis: a case report.
    Kubo C; Nagata S; Fukuda T; Kano R; Tanaka T; Nakanishi K; Ohsawa M; Nakatsuka SI
    Diagn Pathol; 2018 Jun; 13(1):43. PubMed ID: 29960592
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Distinct gene alterations with a high percentage of myeloperoxidase-positive leukemic blasts in de novo acute myeloid leukemia.
    Kamijo R; Itonaga H; Kihara R; Nagata Y; Hata T; Asou N; Ohtake S; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Ogawa S; Naoe T; Kiyoi H; Miyazaki Y
    Leuk Res; 2018 Feb; 65():34-41. PubMed ID: 29306105
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Clinical and pathologic features of extrapleural sarcomatoid mesothelioma].
    Wei MC; Yang SJ
    Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):559-564. PubMed ID: 28810297
    [No Abstract]    [Full Text] [Related]  

  • 19. NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis.
    Struski S; Lagarde S; Bories P; Puiseux C; Prade N; Cuccuini W; Pages MP; Bidet A; Gervais C; Lafage-Pochitaloff M; Roche-Lestienne C; Barin C; Penther D; Nadal N; Radford-Weiss I; Collonge-Rame MA; Gaillard B; Mugneret F; Lefebvre C; Bart-Delabesse E; Petit A; Leverger G; Broccardo C; Luquet I; Pasquet M; Delabesse E
    Leukemia; 2017 Mar; 31(3):565-572. PubMed ID: 27694926
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. bone marrow fibrosis in myelodysplastic syndromes: a prospective evaluation including mutational analysis.
    Ramos F; Robledo C; Izquierdo-García FM; Suárez-Vilela D; Benito R; Fuertes M; Insunza A; Barragán E; Del Rey M; García-Ruiz de Morales JM; Tormo M; Salido E; Zamora L; Pedro C; Sánchez-Del-Real J; Díez-Campelo M; Del Cañizo C; Sanz GF; Hernández-Rivas JM;
    Oncotarget; 2016 May; 7(21):30492-503. PubMed ID: 27127180
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.